OUR PRODUCTS

MOBILE APPS

GENERAL INFO

CLSD

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Clearside Biomedical (CLSD) Earnings Date & Reports

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

CLSD is expected to report earnings to rise 21.50% to -7 cents per share on November 18

Clearside Biomedical CLSD Stock Earnings Reports

Q3'25

Est.

$-0.07

Q2'25

Beat

by $0.04

Q1'25

Missed

by $0.02

Q4'24

Est.

$-0.10

Q3'24

Beat

by $0.02

The last earnings report on August 18 showed earnings per share of -5 cents, beating the estimate of -10 cents. With 611.21K shares outstanding, the current market capitalization sits at 33.21M.

View a ticker or compare two or three

Compare

CLSD

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For CLSD
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CLSD showed earnings on August 18, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of drug therapies to treat chronic, blinding diseases of the eye

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

900 North Point Parkway

Phone

+1 678 270-3631

Employees

Web

https://www.clearsidebio.com